QSS
TXMD icon

Quantitative Systematic Strategies’s TherapeuticsMD TXMD Stock Holding History

Quantitative Systematic Strategies’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-323
Closed -$106K – 874
2018
Q3 		$106K Buy
+323
New +$99K 0.02% 568
2015
Q3 		– Sell
-2,049
Closed -$770K – 532
2015
Q2 		$770K Buy
2,049
+475
+30% +$168K 0.17% 195
2015
Q1 		$488K Buy
+1,574
New +$384K 0.13% 203

Other funds holding TXMD

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Quantitative Systematic Strategies's TXMD Position: Q4 2018 in Review

Quantitative Systematic Strategies sold out of TherapeuticsMD (TXMD) in Q4 2018, closing a stake of 323 shares — an estimated $106K sold.

Quantitative Systematic Strategies first reported a position in TXMD in Q1 2015 and held it in 3 quarters. The position peaked at $770K in Q2 2015. 140 funds tracked by Wall St. Rank hold TXMD as of Q4 2018.

  • Quantitative Systematic Strategies reported no remaining TherapeuticsMD position as of Q4 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 323 TherapeuticsMD shares in Q4 2018, an estimated $106K.
  • Quantitative Systematic Strategies first reported a position in TherapeuticsMD in Q1 2015 and held it in 3 quarters.
  • Quantitative Systematic Strategies's TherapeuticsMD position peaked at $770K in Q2 2015.
  • 140 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2018, filed 12 Feb 2019.